Japan Changes Rules On Drug Names, Study Codes In Sponsors' Trial Sites
Executive Summary
Japanese health ministry makes changes around the allowance of drug generic names and study codes in information provided by pharma companies on their websites for clinical studies, with the aims of improving transparency and facilitating patient participation.